Table 1 Indications of mucosal-related diseases
From: Mucosal immune response in biology, disease prevention and treatment
Diseases | Primary localization | Clinical symptoms | Pathogenesis | Mucosal immune response | Refs. |
---|---|---|---|---|---|
Adenoidal hypertrophy | URT | The enlarged adenoid may cause obstructions of nasal passages and eustachian tubes, persistent congestion, nasal drainage, sinusitis, otitis media; | Chronic infection (e.g., Streptococcus pyogenes) and allergy (e.g., house dust mites), acid reflux elicit lasting inflammation; | Abnormalities in the number and function of various lymphocyte subsets in the adenoid; | |
Herpangina | URT | A high fever and blister-like sores in the mouth and throat; | Infection of Coxsackievirus-A, Enterovirus-A and Echovirus; | Serotype-specific antibody response, macrophage proliferation and phagocytosis enhancement; | |
Allergic rhinitis | URT | Nasal congestion, clear rhinorrhea, sneezing, postnasal drip, and nasal pruritis; | Common allergens including pollen, mould spores, house dust mites, and flakes of skin or droplets of urine or saliva from certain animals; | Th2 cell-induced IgE response, histamine secretion by mast cells, IL-4 and IL-13 facilitating the infiltration of eosinophils, T-lymphocytes, and basophils; | |
Mucous membrane pemphigoid (one of autoimmune blistering disorders) | URT | Red, blistering lesions, ulceration, and subsequent scarring; | Linear deposition of IgG, IgA, or C3 along the epithelial basement membrane zone | ||
Seasonal influenza | URT/LRT | Fever, nonproductive cough, headache, muscle and joint pain, sore throat and a runny nose; | Infection of influenza A or B viruses; | Collaborative neutralization reactions of SIgA and IgG in LRT, induction of autonomous memory of alveolar macrophages; | |
Respiratory syncytial virus infection | URT/LRT | rhinorrhea, nasal congestion, cough, sneezing, and bronchiolitis or even viral pneumonia; | Infection of respiratory syncytial virus; | IL-17-dominated immune response, neutrophilic inflammation; | |
Pulmonary tuberculosis | LRT | Dyspnea, prolonged cough with mucus, pleuritic chest pain, hemoptysis; | Infection of Mycobacterium tuberculosis, macrophage aggregation induced granuloma formation to evade immune clearance; | Alveolar macrophages phagocytosis and production of cytokines such as TNF-α and IFN-γ, T-cell recruitment in granuloma; | |
Pneumocystis pneumonia | LRT | Fever, nonproductive cough, dyspnea, and hypoxemia; with diffuse bilateral ground- | Infection of Pneumocystis; jirovecii in immunocompromised | Alveolar macrophage phagocytosis and production of IFN-γ, TNF-α, IL-1, IL-6; and GM-CSF, protective |
 |  | glass opacities on chest imaging; | patients (like HIV patients); | immune response of SIgM; |  |
Pneumoconiosis | LRT | Long-term cough with mucus, shortness of breath and chest tightness, subpleural honeycombing and fibrosis; | Inhaled airborne dust and fibers induced macrophage dysfunction and interstitial lung disease; | Smaller particles take-up by alveolar macrophages phagocytosis, release of IL-1, TNF-α and lysosomal enzymes, generation of free radicals, and production of extracellular matrix and matrix metalloproteinases by activated fibroblasts; | |
Asthma | LRT | Dyspnea during eat, speak or sleep, wheezing, coughing especially at night or early morning, and chest tightness; | Chronic airway inflammation induced by factors like allergens, infections, obesity, smoking, systemic eosinophilia, leading to airway obstruction and hyperresponsiveness; | Production of thymic stromal lymphopoietin by DCs and injured epithelial cells eliciting Th2-cell type inflammation; | |
Staph infections | URT/LRT/GIT | Antibiotic-associated diarrhea, bacteremia, toxic shock syndrome; | Infection of Staphylococcus aureus; | Junctional integrity alteration of enterocyte, infected epithelial cells eliciting Th2-cell immune response; | |
Crohn’s disease | GIT | Abdominal pain and cramping typically in the lower right abdomen, diarrhea sometimes bloody, fistulas, weight loss, fatigue, fever and anemia, broad inflammation in the whole gastrointestinal tract; | Inflammatory bowel disease induced by multiple factors including genetic, environment, microbiota, overactive immune system; | Th1-cell immune response, high level of TNF-α and IL-12 induced autoimmune reaction; Th cell (e.g., Th17 and regulatory T cell) development hindrance because of microbiota dysbiosis, SIgA deficiency obstructing anti-inflammation reaction; | |
Ulcerative colitis | GIT | Bloody diarrhea, abdominal pain and cramping, weight loss, fatigue, fever and anemia, limited inflammation in the colon and rectum; | Inflammatory bowel disease targeting the colon’s mucosa; | Th2-cell immune response, high level of IL-4 and IL-13, SIgA deficiency obstructing anti-inflammation reaction; | |
Helicobacter pylori infection | GIT | Chronic gastritis, peptic ulcers, dull or burning stomach pain (especially when you have an empty stomach) | Infection of Helicobacter pylori; | Th1-cell immune response, generation and activation of Th17 and regulatory T cells; | |
Celiac disease | GIT | Malabsorptio, diarrhea, fatigue, weight loss, bloating, anemia; | Caused by the ingestion of gluten, proteolytically stable gluten peptides crosslinking with transglutaminase 2 to form complex, the complex eliciting Th1 proinflammatory response and specific antibody production, IFN-γ and IL-15 activating cytotoxicity IELs leading to intestinal epithelial injury; |
Rotavirus infection | GIT | Severe watery diarrhea, vomiting, fever, abdominal pain; | Infection of Rotavirus; | Th1-cell immune response, SIgA contributing to viruses shedding; | |
Cholera | GIT | Severe watery diarrhea, vomiting, thirst, leg cramps, restlessness and irritability; | Infection of Vibrio cholerae; | Increased mucosal-associated lymphocyte homing, protective immune response of SIgA; |